Document is current
Any future updates will be listed below
-
Authors
Chen, Xinrui
Qin, Yan
Xue, Xuemin
Xie, Zucheng
Xie, Tongji
Huang, Liling
Zhu, Haohua
Gao, Lina
Li, Jiangtao
Yang, Jianliang
Gui, Lin
Yang, Sheng
Chen, Haizhu
Feng, Xiaoli
Shi, Yuankai
-
Funding
Funding for this research was provided by:
China National Major Project for New Drug Innovation (2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015, 2017ZX09304015)
Shenzhen High-level Hospital Construction Fund and Guangdong Basic and Applied Basic Research Foundation (2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952, 2023A1515110952)
Shenzhen High-level Hospital Construction Fund
- License Information
-
More Information
Article History
Received: 7 August 2024
Accepted: 18 September 2024
First Online: 3 October 2024
Declarations
:
: The authors declare no competing interests.
: Approved by the institutional review boards of Cancer Hospital Chinese Academy of Medical Sciences.
: Patient’s informed consent is waived.
